Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor.

Abstract

INTRODUCTION Large individual variability in clopidogrel responses has been reported. However, mechanisms of the non-responsiveness are unclear. Our aim was to study the extent of platelet inhibition at the receptor level by in vitro receptor antagonists of P2Y(12) (AR-C69931MX, cangrelor) and P2Y(1) (adenosine 3',5'diphosphate) in aspirin treated patients… (More)
DOI: 10.1016/j.thromres.2009.01.009

Topics

Cite this paper

@article{Lepntalo2009AntiplateletEO, title={Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor.}, author={Aino Lep{\"a}ntalo and Kari Virtanen and Julio C. Res{\'e}ndiz and Jussi Mikkelsson and Leena E. Viiri and Pekka J. Karhunen and Riitta Lassila}, journal={Thrombosis research}, year={2009}, volume={124 2}, pages={193-8} }